Partners Partners

VSV-EBOVAC brings together 12 leading international, both clinical and high tech, vaccine research institutes from 6 EU countries and USA as well as two African clinical sites. The partners provide state-of-the art facilities and clinical vaccination research infrastructures that will work together to facilitate Ebola vaccine development.

The VSV-EBOVAC project is coordinated by the Sclavo Vaccines Association (www.sclavo.org), a non-profit organization devoted to support research and development of human vaccines.

 

 

VSV-EBOVAC Partners: 

Sclavo Vaccines Association (IT) Sclavo Vaccines Association Logo
University of Geneva (CH) University of Geneva logo
BioProtection Systems (US) BioProtection Systems logo
Academisch Ziekenhuis Leiden (NL) Academish Ziekenhuis Leiden logo
University of Gothenburg (SE) University of Gothenburg logo
University of Siena (IT) University of Siena logo
Emory University (US) Emory university logo
The Chancellor, Masters and Scholars of the University of Oxford (UK)  The Chancellor, Masters and Scholars of the University of Oxford logo
Eberhard Karls Universitaet Tuebingen (DE)  Eberhard Karls Universitaet Tuebingen logo
MICROBIOTEC srl (IT)

 

 

Spiez Laboratory, Federal Office for Civil Protection (CH)

 

 

Department of Health, Medicines and Healthcare Products Regulatory Agency -National Institute for Biological Standards and Control (UK)

 

Third Parties:

 
KEMRI/Wellcome Trust Laboratories (KE) KEMRI/Wellcome Trust Laboratories logo
Centre de Recherches Médicales de Lambaréné (GA) Centre de Recherches Médicales de Lambaréné logo

 

Partners photo